ArcticZymes
Business Services · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Sykehusveien 23, Tromso, Troms, 9019, No...Phone Number
+47 77648900Website
www.arcticzymes.comRevenue
<$5 MillionStock Symbol
AZTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About ArcticZymes
ArcticZymes Technologies specializes in providing leading enzymes for biomanufacturing and diagnostics, focusing on innovative solutions tailored to unique challenges in molecular research. With over 30 years of expertise, the company offers a range of products including nucleases, polymerases, and ELISA kits, designed for high-salt and low-temperature environments. Their intended clients include researchers and manufacturers in the fields of therapeutics, gene therapy, and molecular diagnostics. The company emphasizes collaboration and innovation to enhance the efficiency and effectiveness of their clients' work.Explore more
ArcticZymes Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ArcticZymes your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
ArcticZymes, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if ArcticZymes is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if ArcticZymes has recently received funding, and reach out quickly before it becomes old news!
Click to see if ArcticZymes had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at ArcticZymes
Earning: See what the market has to say on ArcticZymes recently announced quarterly report
Funding: Get notified immidiatlly once ArcticZymes has new funding data
Product Launch: Get notified when ArcticZymes launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
ArcticZymes is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ArcticZymes is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ArcticZymes.
ArcticZymes Tech Stack
A closer look at the technologies used by ArcticZymes
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Project
, according to a mid-level source in advertising & promotion, is planning to begin initiatives related to product information management (PIM) within six to nine months.
Advertising, Product Management, Information Governance
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to email marketing. The organization is currently evaluating Mailchimp, Salesforce Email Studio, and Zoho Campaigns.
Digital Marketing, Advertising, Sales, Email, Messaging, Marketing Operations
Project
, according to a mid-level source in advertising & promotion, is in the midst of initiatives related to video marketing.
Digital Marketing, Advertising, Video
Project
Partnership, Digital Marketing, Advertising, Relationship Marketing, Channel Sales, Marketing Relationships
ArcticZymes News & Media
rcticZymes Technologies - Primary insider trading
(Tromsø 11 November 2024) Olav Lanes, VP R&D and applications has on 11 November purchased 5.000 shares in ArcticZymes Technologies ASA for NOK 13,90 per share. Following this transaction holds Mr. Lanes 7.000 shares and 100.000 options in the company. Marit Sjo Lorentzen, VP Operations has on 11 November purchased 5.000 shares in ArcticZymes Technoloiges ASA for NOK 13.88 per share. Following this transaction holds Mrs. Lorentzen 25.331 shares and 100,000 options in the company.ArcticZymes Technologies - Primary insider trading
(Tromsø 06 November 2024) Frank Mathias, Chairman of the Board has on 06 November purchased 7.000 shares in ArcticZymes Technologies ASA for EUR 1.242 per share. Following this transaction holds Mr. Mathias 7.000 shares in the company. Børge Sørvoll, CFO has on 6 November purchased 5.000 shares in ArcticZymes Technoloiges ASA for NOK 14.00 per share. Following this transaction holds Mr. Sørvoll 100.428 shares and 280,000 options in the company. This information is subject toArcticZymes Technologies announces commercial strategic Transformation and Q3 2024 Financial results
Tromsø, Norway, November 6th, 2024 – ArcticZymes Technologies (OSE: AZT) reported revenues of NOK 24.1 million and an EBITDA of NOK -2.3 million for the third quarter of 2024. Financial Highlights: · Revenue for Q3 2024 was NOK 24.1 million, compared to NOK 31.2 million in Q3 2023. Year-to-date revenue totals NOK 81.7 million (9M 2023: NOK 90.6 million). · Revenue for the quarter was in particular impacted by lower sales to two key accounts.ArcticZymes Highlights Industry-Leading Success at ESGCT 2024
Rome, Italy – October 24, 2024 – ArcticZymes Technologies ASA (OSE: AZT), a global leader in enzyme innovation for bioprocessing, is excited to unveil breakthrough developments presented at the prestigious European Society of Gene and Cell Therapy (ESGCT) 2024 conference. The annual ESGCT conference is renowned for spotlighting breakthrough innovations in gene and cell therapy. It acts as a global stage for companies to showcase the latest scientific and technological achievements impacting thei
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding ArcticZymes
Sign Up For FreeTo access detailed company insights
ArcticZymes Technologies specializes in providing leading enzymes for biomanufacturing and diagnostics, focusing on innovative solutions tailored to unique challenges in molecular research. With over 30 years of expertise, the company offers a range of products including nucleases, polymerases, and ELISA kits, designed for high-salt and low-tempera... Read More
